Table 2.
Recommended childhood primary immunisation schedule in China and coverage of the immunisation status for each vaccine (%)
| Vaccine 1 | Vaccination coverage % | χ2 | P | Age-appropriate vaccination coverage % | χ2 | P | ||
|---|---|---|---|---|---|---|---|---|
| L-b children | N-l-b children | L-b children | N-l-b children | |||||
| BCG | 97·5 | 98·7 | 3·832 | 0·041 | 92·1 | 93·5 | 1·076 | 0·176 |
| OPV1 | 95·5 | 96·8 | 1·322 | 0·125 | 82·6 | 86·7 | 4·611 | 0·019 |
| OPV2 | 92·4 | 94·5 | 2·474 | 0·072 | 81·7 | 85·8 | 4·322 | 0·023 |
| OPV3 | 91·3 | 92·1 | 0·221 | 0·319 | 77·4 | 82·5 | 5·420 | 0·021 |
| DPT1 | 93·7 | 94·1 | 03·22 | 0·319 | 73·5 | 81·2 | 11·575 | <0·001 |
| DPT2 | 91·7 | 93·2 | 0·117 | 0·409 | 79·9 | 86·7 | 11·537 | <0·001 |
| DPT3 | 90·8 | 93·1 | 1·085 | 0·174 | 75·4 | 81·2 | 6·826 | 0·005 |
| HepB1 | 98·2 | 98·9 | 1·047 | 0·193 | 91·1 | 96·5 | 17·742 | 0·023 |
| HepB2 | 93·2 | 94·5 | 1·039 | 0·182 | 81·5 | 91·7 | 23·386 | <0·001 |
| HepB3 | 91·5 | 94·3 | 3·955 | 0·023 | 80·1 | 90·3 | 29·391 | <0·001 |
| MV | 91·5 | 93·9 | 2·403 | 0·037 | 70·5 | 80·2 | 17·328 | <0·001 |
| All-course | 89·1 | 92·7 | 5·320 | 0·013 | 65·7 | 79·9 | 35·162 | <0·001 |
BCG, Bacilli Calmette–Guérin vaccine; OPV, oral poliovirus vaccine; DPT, diphtheria–tetanus–pertussis vaccine; HepB, hepatitis B vaccine; MV, measles-containing vaccine; L-b, left-behind; N-l-b, non-left-behind.